#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleomorphic leiomyosarcoma Autologous haematopoietic stem cell transplant Polycystic liver disease Paget's disease of the vulva Rosai-Dorfman syndrome Neuroblastoma recurrent Progressive supranuclear palsy Peripheral primitive neuroectodermal tumour of soft tissue Penile cancer Mantle cell lymphoma stage II Raynaud's phenomenon Oesophageal carcinoma Transient ischaemic attack Oropharyngeal cancer recurrent Medulloblastoma More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Life with Disease Sjogren’s syndrome – Trials in Disease Soft tissue sarcoma – Trials in Disease Alexander disease – Treatment Rhabdomyosarcoma recurrent Hereditary ataxia – Trials in Disease Sarcoidosis – Life with Disease Methylmalonic acidaemia – Basic Information Gaucher’s disease type III – Life with Disease Alagille syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cln-081 Boserolimab Esomeprazole Magnesium Aon-D21 Levocetirizine Dihydrochloride Hdp-101 Mepacrine Alnuctamab BENZYLPENICILLIN POTASSIUM Valganciclovir Axicabtagene Ciloleucel Telitacicept Quinidine Sulfate ULEFNERSEN Spironolactone Tak-280 Teplizumab Flucloxacillin Ivermectin Ganciclovir Sodium More therapies…

    Learn about Your Condition

    Cholangitis sclerosing Coronary artery occlusion Ventricular extrasystoles Microvillous inclusion disease HER2 protein overexpression Incisional hernia Osteoporosis postmenopausal Primary hyperaldosteronism Peripheral artery angioplasty Hypoglycaemia Pelizaeus-Merzbacher disease Colon cancer Osteotomy Intervertebral disc protrusion Acute promyelocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Vitamin D3 (Colecalciferol) Supplementation in Young Adults and Seniors to Compare Effects and Develop Age-Specific Models

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    Czechia

  • Study Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated Drugs:
    • Relatlimab
    • Nivolumab
    • Pemetrexed Disodium
    Austria Belgium Denmark France Germany Ireland +6

  • Study on the Effectiveness of Clostridium Botulinum Neurotoxin Type A for Reducing Wrinkles in Adults

    Recruiting

    4 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands

  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia
    • Neurodegenerative disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    Sweden

  • Study on the Effectiveness of Amoxicillin and Clavulanic Acid in Treating Chronic Wet Cough in Young Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cough
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    Norway

  • Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • DNL593
    • Famotidine
    Belgium Czechia France Italy The Netherlands Portugal +1
Previous Page
1 … 185 186 187 188 189 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!